COVID-19 Among Patients With Multiple Sclerosis

Updated rapid risk assessment from ECDC on coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK

(2020)   Eurosurveillance

Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020

(2020) Timothy W Russell et al.   Eurosurveillance

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

(2020) Safiya Richardson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical characteristics of 3,062 COVID-19 patients: a meta-analysis

(2020) Jieyun Zhu et al.   JOURNAL OF MEDICAL VIROLOGY

The effect of age on mortality in patients with Covid-19: a metanalysis with 611,583 subjects

(2020) Clara Bonanad et al.   Journal of the American Medical Directors Association

Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic

(2020) Wallace Brownlee et al.   NEUROLOGY

Hospitalization and Mortality among Black Patients and White Patients with Covid-19

(2020) Eboni G. Price-Haywood et al.   NEW ENGLAND JOURNAL OF MEDICINE

Estimating the burden of SARS-CoV-2 in France

(2020) Henrik Salje et al.   SCIENCE

The COVID-19 pandemic and the use of MS disease-modifying therapies

(2020) Gavin Giovannoni et al.   Multiple Sclerosis and Related Disorders

Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020

(2020) Shikha Garg et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

COVID-19 and MS disease-modifying therapies

(2020) Joseph R. Berger et al.   Neurology-Neuroimmunology & Neuroinflammation

COVID-19 in MS

(2020) James D. Bowen et al.   Neurology-Neuroimmunology & Neuroinflammation

Prevalence of Asymptomatic SARS-CoV-2 Infection

(2020) Daniel P. Oran et al.   ANNALS OF INTERNAL MEDICINE

Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis

(2020) Leiwen Fu et al.   JOURNAL OF INFECTION

Estimates of the severity of coronavirus disease 2019: a model-based analysis

(2020) Robert Verity et al.   LANCET INFECTIOUS DISEASES

An Italian programme for COVID-19 infection in multiple sclerosis

(2020) Maria Pia Sormani   LANCET NEUROLOGY

COVID-19 in multiple sclerosis: The Dutch experience

(2020) Floor C Loonstra et al.   Multiple Sclerosis Journal

COVID-19 in people with multiple sclerosis: A global data sharing initiative

(2020) Liesbet M Peeters et al.   Multiple Sclerosis Journal

Neurological immunotherapy in the era of COVID-19 — looking for consensus in the literature

(2020) Catharina Korsukewitz et al.   Nature Reviews Neurology

Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study

(2020) Gloria Dalla Costa et al.   NEUROLOGICAL SCIENCES

Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis

(2020) Céline Louapre et al.   JAMA Neurology

Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study

(2020) Andrew Clark et al.   Lancet Global Health

B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran

(2020) Farinaz Safavi et al.   Multiple Sclerosis and Related Disorders

COVID-19 outcomes in MS

(2020) Erica Parrotta et al.   Neurology-Neuroimmunology & Neuroinflammation

Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register

(2020) Nikos Evangelou et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Characteristics of COVID-19 disease in multiple sclerosis patients

(2020) Mahdi Barzegar et al.   Multiple Sclerosis and Related Disorders

Infectious Complications of Multiple Sclerosis Therapies: Implications for Screening, Prophylaxis, and Management

(2018) David J Epstein et al.   Open Forum Infectious Diseases

Fatigue in Multiple Sclerosis: Mechanisms, Evaluation, and Treatment

(2017) Tiffany J. Braley et al.   SLEEP

Infection-related health care utilization among people with and without multiple sclerosis

(2016) José MA Wijnands et al.   Multiple Sclerosis Journal

Infection-related health care utilization among people with and without multiple sclerosis

(2016) José MA Wijnands et al.   Multiple Sclerosis Journal

Hospital admission due to infections in multiple sclerosis patients

(2013) S. Montgomery et al.   EUROPEAN JOURNAL OF NEUROLOGY

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

(2010) Andreas Stang   EUROPEAN JOURNAL OF EPIDEMIOLOGY